Fortrea Holdings Inc. Common Stock

FTRENASDAQ • USD
20.31 USD
↗ 0.52 (2.65%)🟢PRE MARKET (AS OF 07:45 AM EST)
🟢Market: OPEN

Shares of Fortrea Holdings Inc. Common Stock (FTRE) are trading at $20.31. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest FTRE is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 16, 2026.

Open?$19.88
High?$20.31
Low?$19.88
Prev. Close?$19.79
Volume?4
Avg. Volume?2.0M
VWAP?$20.11
Rel. Volume?0.00x
Bid / Ask
Bid?$16.77 × 100
Ask?$24.14 × 100
Spread?$7.37
Midpoint?$20.46
Valuation & Ratios
Market Cap?1.9B
Shares Out?96.5M
Float?94.3M
Float %?99.2%
P/E Ratio?N/A
P/B Ratio?3.59
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Employees
14.0K
Market Cap
1.9B
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2023-06-16
Address
8 MOORE DRIVE
DURHAM, NC 27709
Phone: 877-495-0816
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
1
Momentum?
86
Short Sent.?
35
Piotroski F-Score?5/9Mixed
Altman Z-Score?-0.82Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.09%Elevated
Short Interest?8.6M
Days to Cover?3.7
Free Float94.3M
Avg Daily Volume2.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?0.97Weak
Quick Ratio?0.97Weak
Cash Ratio?0.22Low
Debt/Equity?1.98High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
80/100
P/E?
N/A▾
P/B?
Peers
100
S&P
48
3.59FAIR▾
P/S?
Peers
100
S&P
91
0.72CHEAP▾
P/FCF?
Peers
100
S&P
85
11.3CHEAP▾
EV/EBITDA?
Peers
100
S&P
19
22.1HIGH▾
EV/Sales?
Peers
100
S&P
91
1.03CHEAP▾
Returns & Efficiency
ROE?
S&P
9
-12.9%WEAK▾
ROA?
S&P
3
-2.5%WEAK▾
Cash Flow & Enterprise
FCF?$169.0M
Enterprise Value?$2.7B
Fundamentals ratios updated end of day